Header Logo

Payal Gurnani

Concepts (46)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacists
2
2021
16
0.910
 Why?
Marfan Syndrome
1
2018
2
0.620
 Why?
Drug-Eluting Stents
1
2018
14
0.600
 Why?
Extracorporeal Membrane Oxygenation
1
2018
15
0.600
 Why?
Fluid Therapy
1
2010
31
0.350
 Why?
Shock, Septic
1
2010
63
0.340
 Why?
Practice Guidelines as Topic
1
2010
288
0.300
 Why?
Anti-Bacterial Agents
1
2010
338
0.290
 Why?
Professional Role
2
2021
33
0.220
 Why?
Epoprostenol
1
2021
5
0.190
 Why?
Pulmonary Ventilation
1
2021
10
0.190
 Why?
Nebulizers and Vaporizers
1
2021
15
0.190
 Why?
Antihypertensive Agents
1
2021
70
0.180
 Why?
Hypercalcemia
1
2020
10
0.180
 Why?
Calcitonin
1
2020
16
0.180
 Why?
Diphosphonates
1
2020
16
0.180
 Why?
Intubation, Intratracheal
1
2021
93
0.170
 Why?
Patient Care Team
1
2021
132
0.160
 Why?
Pandemics
1
2021
238
0.160
 Why?
Critical Care
1
2021
190
0.160
 Why?
Neoplasms
1
2020
219
0.150
 Why?
Intensive Care Units
1
2019
279
0.130
 Why?
Emergency Service, Hospital
1
2019
228
0.130
 Why?
Humans
6
2021
25965
0.130
 Why?
Adult
3
2021
7349
0.120
 Why?
Male
4
2021
13981
0.110
 Why?
Resuscitation
1
2010
13
0.090
 Why?
Clinical Protocols
1
2010
55
0.090
 Why?
Hospital Mortality
1
2010
130
0.080
 Why?
Multivariate Analysis
1
2010
293
0.080
 Why?
Evidence-Based Medicine
1
2010
185
0.080
 Why?
Middle Aged
3
2021
8508
0.070
 Why?
Cross Infection
1
2010
277
0.070
 Why?
Aged
3
2021
8704
0.070
 Why?
Time Factors
1
2010
1361
0.070
 Why?
Prospective Studies
1
2010
1646
0.060
 Why?
Female
3
2021
14348
0.060
 Why?
Retrospective Studies
2
2021
3288
0.050
 Why?
Reagent Kits, Diagnostic
1
2021
7
0.050
 Why?
Treatment Outcome
1
2010
3292
0.050
 Why?
Administration, Inhalation
1
2021
29
0.050
 Why?
Dose-Response Relationship, Drug
1
2021
315
0.050
 Why?
Case-Control Studies
1
2021
547
0.040
 Why?
Pharmacy Service, Hospital
1
2019
10
0.040
 Why?
Cost Savings
1
2019
29
0.040
 Why?
Critical Illness
1
2019
122
0.040
 Why?
Gurnani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (46)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_